The emerging approach of this peptide represents a major advance in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets multiple pathways – GLP-1 and GIP – providing greater https://tirzepatide-peptide482938.eedblog.com/42293374/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment